Cipla has launched the generic version of Pirfenidone, used to treat Idiopathic Pulmonary Fibrosis, a progressive lung disease. The launch makes
In
The incidence of the illness in India is not known, but is expected to be higher than the prevalence in the US — about 30,000 new cases per year, The disease causes the lung to be replaced by scar tissue – though the cause of the illness is still not clear, varying from environmental illness to smoking, he said. But once it is diagnosed, about 50 per cent die in three years.
crackcrackCompany Name | CMP |
---|---|
Sun Pharma Inds. | 1530.00 |
Dr. Reddys Lab | 5913.95 |
Cipla | 1421.00 |
Zydus Lifesciences | 993.40 |
Lupin | 1684.00 |
View more.. |